Effect of thoracoscopic direct-view intrathoracic intercostal nerve block on postoperative pain and stress in patients undergoing VATS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069138

Enrollment

Unknown

Registered

2023-03-07

Start date

2023-03-13

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Group of Intercostal Nerve Block:Thoracoscopic direct view intrathoracic intercostal nerve block

Group of Control:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 75 years. 2. Patients with a first diagnosis of pulmonary nodules to be operated on by VATS. 3. preoperative assessment ASA classification I-II, cardiac function NYHA class I-II.

Exclusion criteria

Exclusion criteria: 1. presence of a history of allergy to local anesthetics such as ropivacaine 2. the presence of severe hepatic or renal insufficiency, coagulation disorders 3. presence of chronic pain or a history of long-term opioid or NSAID use 4. presence of a history of chest surgery. 5. refusal of the patient to participate in the study. 6. change in surgical approach with intermediate open-heart surgery.

Design outcomes

Primary

Measure	Time frame
Cumulative opioid dose (equivalent morphine dose) 24h postoperatively;	—

Secondary

Measure	Time frame
NRS Score;Inflammatory/immune indicators;	—

Countries

China

Contacts

Public ContactWu Hongliang

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

wuhongliang2021@126.com+86 13466556785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026